80+ Stocks Screened — 41 Qualified, 10 Ranked Highest (One Still Shows ~60%)

Despite the market rebound, expected returns remain elevated — ranked by quality, valuation, and downside risk

The market doesn’t misprice everything.

But when it does…

It rarely does it subtly.

It compresses multiples across entire sectors.
It sells quality alongside risk.
It prices uncertainty… as if it’s permanent.

And that’s where opportunity lives.

This month, I screened over 80 stocks.

Only 41 met the quality threshold.

And from those…

I’ve ranked the 10 highest-conviction opportunities based on expected return, balance sheet strength, and capital efficiency.

One still shows ~60% upside — even after the recent market bounce.

---

---

What’s Happening Right Now

Over the past few weeks, we’ve seen:

• Big Tech rerate from ~24x → ~19–20x forward earnings

• High-quality software names cut in half (in some cases)

• Healthcare trading below historical valuation bands

• Financials drifting despite stable fundamentals

Not because fundamentals collapsed.

But because:

The market is repricing risk - indiscriminately.

And when that happens:

Expected returns improve.

---

Where the Market Looks Most Wrong Right Now

March was about identifying undervalued compounders.

April goes one step further.

This month answers:

“Where is the market most wrong right now?”

Not just cheap stocks.

But:

• High-quality businesses

• With durable earnings power

• Trading below intrinsic value

• Where multiple compression ≠ fundamental deterioration

---

How April’s Spreadsheet Is Built

This month’s ranking framework prioritises:

1️⃣ Mispricing Severity

• % gap to 12-month fair value

• Relative to historical valuation ranges

2️⃣ Quality of the Business

• ROIC

• Free cash flow durability

• Margin structure

• Balance sheet strength

3️⃣ Expected Return Profile

• 12-month expected return

• Bear case return

• Downside asymmetry

4️⃣ Allocation Ranking

A combined score of:

• Upside

• Quality

• Balance sheet

• Risk-adjusted return

---

What Stands Out This Month

---

1️⃣ Big Tech Is No Longer “Expensive”

Names like:

• Microsoft

• Meta

• Amazon

are now trading closer to market multiples than premium ones.

These are businesses with:

• Structural revenue growth

• Massive free cash flow

• Dominant competitive positioning

Yet multiples have compressed as if growth is fading.

The setup today is very different to 2021.

You’re no longer paying peak multiples for peak narratives.

---

2️⃣ Software Has Been Reset

Some of the highest-quality software businesses are now trading at levels not seen in years:

• Intuit

• Adobe

• Salesforce

• ServiceNow

In many cases:

• Revenue growth remains intact

• Margins are stable or improving

• Cash flow is strong

But valuations have reset dramatically.

This is multiple compression - not business deterioration.

---

3️⃣ Healthcare Remains Mispriced

Healthcare continues to offer some of the most asymmetric setups:

• Novo Nordisk

• UnitedHealth

• Zoetis

• Abbott

These businesses benefit from:

• Non-cyclical demand

• Strong pricing power

• Long-term structural growth

Yet many are trading below historical valuation norms.

---

4️⃣ “Boring” Compounders Are Attractive

Names the market ignores:

• S&P Global

• ADP

• MSCI

• Accenture

These are:

• High-margin

• Asset-light

• Recurring revenue businesses

They rarely look exciting.

But they consistently compound.

And when they dip below fair value…

That’s where long-term returns are built.

---

How To Use This Spreadsheet

This is not a “buy everything” list.

If I were deploying fresh capital today…

this is where I’d start.

It’s a capital allocation tool.

You can approach it in three ways:

→ Highest Upside

Focus on:

• % from fair value

• Expected return

→ Highest Quality

Focus on:

• ROIC

• Balance sheet strength

• Margin profile

→ Balanced Allocation

Use:

• Allocation ranking

• Conviction tiers

---

Risk Context

Not every name here is immune to volatility.

Some will:

• Fall further in a recession

• Trade sideways for months

• Look “wrong” before they look right

That’s why the framework includes:

• Bear case returns

• Balance sheet filters

• Quality scoring

Risk doesn’t disappear when valuations compress.
But expected returns improve.

---

Why This Matters Now

Markets don’t reward patience immediately.

They test it first.

The best opportunities:

• Don’t feel obvious

• Don’t come with certainty

• Don’t look comfortable

They come when:

• Quality is sold

• Narratives turn negative

• And valuations quietly reset

---

What Paid Members Get

Premium members receive:

• Two fully updated spreadsheets per month

• Ranked capital allocation tables

• 12-month expected return modelling

• Conviction tiers

• Ongoing valuation updates

For £200/year, this is built for investors who want to operate with a clear framework - not guesswork.

This is designed for investors who want:

• Structure

• Discipline

• Repeatable decision-making

Not noise.

If you’re serious about improving your decision-making, this is where to start.

---

April Spreadsheet Below